Abstract-Apolipoproteins of high density lipoprotein (HDL) and especially apolipoprotein (apo)AI and apoAII have been demonstrated as binding directly to the class B type I scavenger receptor (SR-BI), the HDL receptor that mediates selective cholesteryl ester uptake. However, the functional relevance of the binding capacity of each apolipoprotein is still unknown. The human adrenal cell line, NCI-H295R, spontaneously expresses a high level of SR-BI, the major apoAI binding protein in these cells. As previously described for murine SR-BI, free apoAI, palmitoyl-oleoylphosphatidylcholine (POPC)-AI, and HDL are good ligands for human SR-BI. In vitro displacement of apoAI by apoAII in HDLs or in Lp AI purified from HDL by immunoaffinity enhances their ability to compete with POPC-AI to bind to SR-BI and also enhances their direct binding capacity. The next step was to determine whether the higher affinity of apoAII for SR-BI correlated with the specific uptake of cholesteryl esters from these HDLs. Free apoAII and, to a lesser extent, free apoAI that were added to the cell medium during uptake experiments inhibited the specific uptake of [ 3 H]cholesteryl esters from HDL, indicating that binding sites on cells were the same as cholesteryl ester uptake sites.In direct experiments, the uptake of [ 3 H]cholesteryl esters from apoAII-enriched HDL was highly reduced compared with the uptake from native HDL. These results demonstrate that in the human adrenal cell line expressing SR-BI as the major HDL binding protein, efficient apoAII binding has an inhibitory effect on the delivery of cholesteryl esters to cells. iver and adrenal selective uptake of HDL cholesteryl esters (CEs) appears to be a receptor-mediated process. The class B type I scavenger receptor (SR-BI), a molecularly well-defined cell surface HDL receptor for selective cholesterol uptake, has recently been identified. 1 First described in rodents, its human analogue, initially called CLA-1, has a protein sequence identity close to that of the rodent receptor. 2,3 Selective uptake of CE does not involve endocytic uptake and lysosomal degradation of lipoprotein particles. The first step in the cellular mechanism of this pathway involves HDL binding and then the incorporation of HDLderived CE into the plasma membrane. 4 After uptake, CEs are directed intracellularly to a nonlysosomal destination for degradation. 5 In mice, SR-BI is largely expressed in liver, and overexpression of the SR-BI level in vivo on hepatocytes induces the disappearance of plasmatic HDL and the doubling of biliary cholesterol 6 ; inversely targeted disruption of the SR-BI gene induces a 2.2-fold increase in plasma cholesterol concentration. 7 All these results strongly suggest that SR-BI plays a key role in hepatic HDL metabolism in rodents. Also in rodents, SR-BI seems to play an important role in the maternal-fetal lipoprotein transport system during embryogenesis. 8 Azhar et al 9 have shown that the induction of the SR-BI receptor and the HDL-selective cholesterol uptake pathway in r...